Literature DB >> 21325018

Early failure of N-methyl-D-aspartate receptors and deficient spine formation induced by reduction of regulatory heme in neurons.

Tatyana Chernova1, Joern R Steinert, Paul Richards, Rajendra Mistry, R A John Challiss, Rebekah Jukes-Jones, Kelvin Cain, Andrew G Smith, Ian D Forsythe.   

Abstract

An initial stage of many neurodegenerative processes is associated with compromised synaptic function and precedes synapse loss, neurite fragmentation, and neuronal death. We showed previously that deficiency of heme, regulating many proteins of pharmacological importance, causes neurodegeneration of primary cortical neurons via N-methyl-d-aspartate receptor (NMDAR)-dependent suppression of the extracellular signal-regulated kinase 1/2 pathway. Here, we asked whether the reduction of heme causes synaptic perturbation before neurite fragmentation in neuronal cultures and investigated molecular mechanisms of synaptic dysfunction in these cells. We showed the change in the NR2B subunit phosphorylation that correlates with compromised NMDAR function after the reduction of regulatory heme and a rapid rescue of NR2B phosphorylation and NMDAR function by exogenous heme. Electrophysiological recordings demonstrated diminished NMDAR currents and NMDAR-mediated calcium influx after 24 h of inhibition of heme synthesis. These effects were reversed by treatment with heme; however, inhibition of the Src family kinases abolished the rescue effect of heme on NMDA-evoked currents. Diminished NMDAR current and Ca(2+) influx resulted in suppressed cGMP production and impairment of spine formation. Exogenous heme exerted rescue effects on NR2B tyrosine phosphorylation and NMDA-evoked currents within minutes, suggesting direct interactions within the NMDAR complex. These synaptic changes after inhibition of heme synthesis occurred at this stage without apparent dysfunction of major hemoproteins. We conclude that regulatory heme is necessary in maintaining NR2B phosphorylation and NMDAR function. NMDAR failure occurs before neurite fragmentation and may be a causal factor in neurodegeneration; this could suggest a route for an early pharmacological intervention.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21325018     DOI: 10.1124/mol.110.069831

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  5 in total

1.  Disordered porphyrin metabolism: a potential biological marker for autism risk assessment.

Authors:  Nicholas J Heyer; Diana Echeverria; James S Woods
Journal:  Autism Res       Date:  2012-02-01       Impact factor: 5.216

2.  Measurement of Heme Synthesis Levels in Mammalian Cells.

Authors:  Jagmohan Hooda; Maksudul Alam; Li Zhang
Journal:  J Vis Exp       Date:  2015-07-09       Impact factor: 1.355

3.  Altered urinary porphyrins and mercury exposure as biomarkers for autism severity in Egyptian children with autism spectrum disorder.

Authors:  Eman M Khaled; Nagwa A Meguid; Geir Bjørklund; Amr Gouda; Mohamed H Bahary; Adel Hashish; Nermin M Sallam; Salvatore Chirumbolo; Mona A El-Bana
Journal:  Metab Brain Dis       Date:  2016-07-13       Impact factor: 3.584

4.  Influence of Iron Deficiency on Olfactory Behavior in Weanling Rats.

Authors:  V M Ruvin Kumara; Marianne Wessling-Resnick
Journal:  J Behav Brain Sci       Date:  2012

5.  Modification of neurobehavioral effects of mercury by a genetic polymorphism of coproporphyrinogen oxidase in children.

Authors:  James S Woods; Nicholas J Heyer; Diana Echeverria; Joan E Russo; Michael D Martin; Mario F Bernardo; Henrique S Luis; Lurdes Vaz; Federico M Farin
Journal:  Neurotoxicol Teratol       Date:  2012-07-02       Impact factor: 3.763

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.